Global Commercialization of Applied Biosystems 3500 Series Genetic Analyzers Sets New Standards for Throughput, Data Quality and Ease-of-Use

CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use. The 3500 Series Genetic Analyzer is for research use only not intended for therapeutic or diagnostic use.